SGRY Past Earnings image   This SGRY past earnings page last updated 6/14/2024
SGRY Past Earnings
PeriodPast Earnings DateAdj. EPS
Q1 20245/7/20240.100
Q4 20232/26/20240.440
Q3 202311/7/20230.190
Q2 20238/1/20230.280
Q1 20235/1/20230.080
Q4 20223/1/20230.270
Q3 202211/8/2022-0.020
Q2 20228/2/2022-0.030
Q1 20225/3/2022-0.090
Q4 20212/28/20220.230
Q3 202111/2/2021-0.050
Q2 20218/4/20210.000
Q1 20215/5/2021-0.300
Q4 20203/10/20210.090
Q3 202011/4/2020-0.530
Q2 20208/5/2020-0.480
Q1 20205/11/2020-0.340
Q4 20193/5/20200.100
Q3 201911/5/2019-0.280
Q2 20198/7/2019-0.290
Q1 20195/8/2019-0.420
Q4 20183/13/2019-1.17
Q3 201811/7/2018-0.19
Q2 20188/9/2018-0.18
Q1 20185/9/2018-0.26
Q4 20173/1/2018-0.03
Q3 201711/8/20170.15
Q2 20178/8/2017-0.01
Q1 20175/9/20170.04
Q4 20163/9/20170.19
Q3 201611/9/20160.21
Q2 20168/9/20160.16
Q1 20165/5/20160
Q4 20153/10/20160.35
Q3 201511/12/20150.04
SGRY Past Revenue
PeriodPast Earnings DateGAAP
Q1 20245/7/20240.72B
Q4 20232/26/20240.74B
Q3 202311/7/20230.67B
Q2 20238/1/20230.67B
Q1 20235/1/20230.67B
Q4 20223/1/20230.71B
Q3 202211/8/20220.62B
Q2 20228/2/20220.62B
Q1 20225/3/20220.60B
Q4 20212/28/20220.61B
Q3 202111/2/20210.56B
Q2 20218/4/20210.54B
Q1 20215/5/20210.51B
Q4 20203/10/20210.55B
Q3 202011/4/20200.50B
Q2 20208/5/20200.37B
Q1 20205/11/20200.44B
Q4 20193/5/20200.52B
Q3 201911/5/20190.45B
Q2 20198/7/20190.45B
Q1 20195/8/20190.42B
Q4 20183/13/2019491.17M
Q3 201811/7/2018443.93M
Q2 20188/9/2018444.77M
Q1 20185/9/2018417.37M
Q4 20173/1/2018460.35M
Q3 201711/8/2017329.91M
Q2 20178/8/2017288.35M
Q1 20175/9/2017286.18M
Q4 20163/9/2017306.00M
Q3 201611/9/2016282.68M
Q2 20168/9/2016289.68M
Q1 20165/5/2016267.07M
Q4 20153/10/2016263.32M
Q3 201511/12/2015239.60M
Quotes delayed 20 minutes

Email EnvelopeFree SGRY Email Alerts:
Get Dividend Alerts
Get SEC Filing Alerts
10 Most Oversold S&P 500 Stocks
10 Most Overbought S&P 500 Stocks
10 ETFs With Stocks Insiders Are Buying
10 ETFs With Most Upside To Targets
The DividendRank Top 25
Warren Buffett Dividend Stocks
10 Cheap Dividend Stocks Under $10
10 Top DividendRank'ed Energy Stocks
The 10 Highest Yielding Preferred Stocks
The 10 Highest Yielding Preferred Stocks
The 15 Most Active S&P Call & Put Options
Surgery Partners (SGRY) is categorized under the Healthcare sector; to help you further research past earnings across stocks, below are some other companies in the same sector:

SGTX Past Earnings
SHC Past Earnings
SIBN Past Earnings
SIEN Past Earnings
SIGA Past Earnings
SILK Past Earnings
SINT Past Earnings
SIOX Past Earnings
SKIN Past Earnings
SLDB Past Earnings

SGRY Past Earnings Q&A

What was the best and worst SGRY past earnings results?
For Surgery Partners, I'm wondering what the company's very best and worst earnings results have been, on an earnings per share basis?

✔️Accepted answer: The highest SGRY past earnings result in our data set was 0.440/share posted in Q4 2023, while the lowest was in Q4 2018 when SGRY posted -1.17/share.

  Suggested answer: The biggest top line earnings performance — aka revenue — quarter was in Q4 2023 when SGRY reported 0.74B in revenue, while the quarter with the lowest revenue in our data set was Q3 2015 at 239.60M of revenue.

  Suggested answer: There are 35 SGRY past earnings results in our data set.

On this page we presented the SGRY past earnings date information for Surgery Partners. Reviewing that SGRY Past Earnings for the company, we see that the highest past earnings result in our data set was in Q4 2023, when SGRY posted adjusted EPS of 0.440/share. Meanwhile the lowest SGRY past earnings result was in Q4 2018, when SGRY posted adjusted EPS of -1.17/share. Turning to top line revenue performance, the biggest revenue quarter in our data set was seen in Q4 2023 when SGRY reported 0.74B in revenue, while the smallest revenue quarter was Q3 2015 when SGRY reported 239.60M in revenue.

Any self directed investor doing their due diligence on SGRY or any other given stock can benefit from researching all of the Surgery Partners past earnings — and here, we present each quarter's result all together on one page for easy comparison. Studying this information can help when projecting future earnings, as well as determining whether the past earnings trajectory justifies the current stock value. That's why we bring you to make it easy for investors to investigate Surgery Partners past earnings, or the past earnings information for any stock in our coverage universe. And in your continued research we hope you will be sure to check out the further links included for earnings surprises history (beat/miss data) as well as next earnings dates for SGRY. Thanks for visiting, and the next time you need to research SGRY past earnings or those of another stock, we hope you'll think of our site, as your go-to past earnings research resource of choice.

Recommended: Institutional Holders of AMCF, TXMD YTD Return, EFX RSI.


SGRY Past Earnings | | Copyright © 2020 - 2024, All Rights Reserved

Nothing in is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.
Wait! Don't leave yet.
Want to receive our latest research absolutely free?

Click the button below for your complimentary copy of Your Early Retirement Portfolio: Dividends Up to 8.7%—Every Month—Forever.

You'll discover the details on 4 stocks and funds that pay you massive dividends as high as 8.7%.